Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Atragen

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
PURPOSE To determine single-and multiple-dose pharmacokinetics of liposomal-all- trans -retinoic acid (Atragen) following… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2000
2000
ATRAGEN® is a liposome-encapsulated intravenous (IV) formulation of the anticancer drug all-trans-retinoic acid (tretinoin… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1999
1999
All-trans retinoic acid (ATRA) is currently widely used in the therapy of acute promyelocytic leukimia and is being testedin… Expand
Is this relevant?
1998
1998
The objective of the proposed study was to determine the distribution in plasma lipoprotein of free all-trans retinoic acid (ATRA… Expand
Is this relevant?